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ABSTRACT  
A novel nano- and micro-integrated protein chip (NMIPC) that can detect proteins with ultrahigh sensitivity 
has been fabricated. A microfl uidic network (μFN) was used to construct the protein chips, which allowed facile 
patterning of proteins and subsequent biomolecular recognition. Aqueous phase-synthesized, water-soluble 
fl uorescent CdTe/CdS core-shell quantum dots (aqQDs), having high quantum yield and high photostability, 
were used as the signaling probe. Importantly, it was found that aqQDs were compatible with microfluidic 
format assays, which afforded highly sensitive protein chips for cancer biomarker assays.
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Introduction
Protein microarrays [1 3] have shown great promise 
in both basic and applied biological research [4 7]. 
This miniaturized multi-target analysis technology 
is particularly useful in molecular diagnostics, e.g., 
early-stage detection of tumor biomarkers in blood 
sera, cell lines and on the membranes of blood cells 
[7]. However, protein microarray technology is still 
faced with several challenge [8], such as relatively 
low sensitivity.
In this regard, semiconductor quantum dots 
(QDs) have shown unprecedented advantages, 
such as high quantum yield and photostability, and 
size-dependent tunable photoluminescence with 
narrow emission bandwidth and broad excitation 
spectra [9 12]. During the past two decades, 
considerable advances have been made in the 
areas of synthesis and biological applications of 
high quality QDs [13 18]. For example, Baba and 
coworkers have demonstrated that QDs bring about 
significantly improved sensitivity in western blot-
based protein detection [19], which potentially 
means that the information from low abundance 
proteins could be elucidated. Nevertheless, in order 
to meet the requirements of biological applications, 
QDs synthesized in an organic phase have to be 
transferred to aqueous solution, which is rather 
complicated and often associated with significant 
losses of both photoluminescence (PL) quantum 
Nano Research
491Nano Res (2008) 1: 490 496
yield (QY) and stability [20 22]. In order to avoid 
these problems, we recently developed a highly 
efficient program process of microwave irradiation 
(PPMI) strategy that allows the synthesis of highly 
fluorescent water-dispersed QDs directly from 
aqueous solution (aqQDs) [23, 24].
Another major obstacle with microarrays lies 
in the complex fabrication process that requires 
expensive automated spotting robots as well as strict 
reaction conditions such as humidity and temperature 
control [2, 25 27]. Microfluidic technology has 
proven to be a promising solution that offers 
convenient operation for both protein immobilization 
and subsequent binding assays [28 33]. In this 
contribution, we describe a novel nano- and micro-
integrated protein chip (NMIPC) that integrates the 
advantages of both microfl uidic networks (μFN) and 
aqQDs, and successfully demonstrates the combined 
advantages of using both aqQDs probes and a μFN 
by using carcinoma embryonic antigen (CEA) as a 
model assay target. This novel NMIPC system offers 
ultrahigh sensitivity for protein assays as well as 
convenience in both chip fabrication and detection, 
and is a potentially promising tool for portable point-
of-care (POC) medical diagnostics.
1. Results and discussion
Capture antibodies (monoclonal antibodies, mAb) 
were first passed through the microfluidic channels 
in the first polydimethylsiloxane (PDMS) layer, 
which resulted in their immobilization on the 
aldehyde-activated slide (see the scheme in Fig. 1). 
Then the remaining area of the slide was blocked 
with bovine serum albumin (BSA) to prevent 
nonspecifi c adsorption in subsequent steps and thus 
reduce the background signal. After this step, the 
fi rst PDMS layer was peeled off and a second PDMS 
layer was attached to the slide, resulting in a crossed-
channel configuration (see details in Fig. S-1 in the 
Electronic Supplementary Material, ESM). Target 
proteins were then passed through these channels, 
crossing the original capture mAb-bound channels, 
forming the μFN. It should be noted that the target 
proteins were captured in the cross-section of the 
μFN. After binding, biotinylated detection antibodies 
(monoclonal antibodies, mAb) were passed through 
the same channels, followed by the signaling probe, 
avidin-coated CdTe/CdS core-shell aqQDs, that 
illuminates the protein binding assays (see Fig. S-1 in 
the ESM for details of the device construction).
Figure 1 Schematic illustration of protein chips based on aqQDs probes and microfl uidic network
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We first tested the sensitivity of the NMIPC by 
using different concentrations of capture antibodies 
(mouse IgG), with either avidin-QDs or avidin-
fluorescein isothiocyanate (FITC) as the signaling 
probe. Avidin-QDs possess approximately the same 
fluorescence properties as aqQDs, and remain well 
dispersed in solution (Figs. S-2 and S-3 in the ESM). 
In addition, a biotinylated polyclonal antibody (goat 
anti-mouse IgG) was employed as a ligand which 
can bind to both mouse IgG and avidin. As shown in 
Fig. 2, the green-colored avidin-QDs probe (λem=554 
nm) exhibited a concentration-dependent change 
in fluorescence intensity in the range 32 pmol/L
3.2 μmol/L. In contrast, the organic dye avidin-
FITC [34], afforded significantly lower fluorescence 
intensities. In the latter case, the signal could not be 
distinguished from the background when the target 
concentration was below 320 nmol/L (four orders 
of magnitude higher than the corresponding value 
for aqQDs). This comparison clearly demonstrates 
that the aqQDs probe is fully compatible with the 
microfl uidic format and affords ultrahigh sensitivity. 
It is known that different colored QDs can be 
excited with a single wavelength due to their broad 
excitation bands. As shown in Fig. 3, protein chips 
labeled with aqQDs of two different colors could be 
effectively excited with a single laser source, implying 
that QDs-based protein chips allow convenient 
multiplex protein detection. In addition, QDs also 
showed high stability toward photobleaching. Figure 
3 compares the photostability of FITC (A) and two 
kinds of aqQDs, B and C (with λem of 554 nm and 
579 nm, respectively) on protein chips. Clearly, 
fl uorescent signals from FITC (A1) largely diminished 
after being irradiated with blue light (λ=450 490 nm) 
for 30 min (A2). In contrast, signals from both aqQDs 
decreased by only a small degree (the discrepancy 
of the background contrast results from the different 
excitation wavelengths for FITC and QDs, and 
possibly also from QD diffusion on the surface of the 
microchannels). In fact, spots for the two QDs probes 
were still visible even after irradiation for 4 h (data 
not shown). This high photostability ensures the 
signal reproducibility of our protein chips.
In order to demonstrate the application of 
the NMIPC system in molecular diagnostics, we 
Figure 2 Comparison of the brightness of avidin-QDs and 
avidin-FITC as signal probes. Inset: the fluorescence images of the 
microfluidic network arrays using the two fluorescent probes with 
the target protein concentration range from 3.2×10-6 mol/L to 3.2×
10-11 mol/L, respectively (up: avidin-QDs, bottom: avidin-FITC) 
Figure 3 Photostability of avidin-QDs and avidin-FITC. A1: fl uorescence images of microfl uidic arrays 
using avidin-FITC probes. B1 and C1: fl uorescence images of microfl uidic arrays using two avidin-QDs 
with emission band at 554 nm and 579 nm, respectively. A2, B2 and C2: corresponded fl uorescence 
image after 30 min photobleaching. In all experiments, monoclonal antibodies were directly immobilized 
on the protein chip, biotinylated secondary antibodies, avidin-QDs or avidin-FITC probes were associated 
on the modifi ed chip by fl owing through the channels
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designed a μFN chip for a tumor marker, CEA, 
with a sandwich-based confi guration as shown in 
Fig. 1. Avidin-coated aqQDs (λem=579 nm) were used 
as a signaling probe for this assay. Figure 4 displays 
a typical dose-response result for CEA over a 
wide concentration range covering six orders 
of magnitude, from 500 nmol/L to 500 fmol/L. 
The limit of detection (LOD) was estimated to be 
500 fmol/L (see Fig. S-4 in the ESM). In contrast, 
protein chips using avidin-FITC as the signaling 
probe showed a detectable signal only when the 
target concentration reached 500 nmol/L. Moreover, 
the fluorescence signal for 500 fmol/L CEA was 
significantly higher than that of alpha-fetoprotein 
(AFP, negative control) with a concentration of 
15 nmol/L, indicating that our NMIPC system 
possesses high detection specifi city (see Fig. S-4 in 
the ESM). It is important to note that since avidin-
QDs remain highly fl uorescent in serum (Figs. S-5 
and S-6 in the ESM), this QD-based protein chip 




Silyated slides (aldehyde activated) were obtained 
from CEL Associates (Pearland, USA). Sylgard184 
was purchased from Dow Corning Co.  Ltd. 
(Shanghai, China). All antigens (target proteins) were 
purchased from Industries International (Concord, 
USA). Monoclonal antibodies and biotinylated 
monoclonal antibodies were purchased from USBIO. 
Biotinylated secondary antibody (anti-mouse 
polyclonal antibody), avidin, avidin-FITC, BSA, 
tellurium powder (99.9%), and CdCl2 (99.9%) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Tween 20 and 3-mercaptopropionic acid (MPA) (98%) 
were purchased from Fluka. Silicon patterns were 
fabricated by Shanghai Institute of Microsystem and 
Information Technology (SIMIT), Chinese Academy 
of Sciences. The syringe pump was obtained from 
Zhejiang University. 
2.2 Fabrication of microfl uidic channels
Polydimethyls i loxane  layers  conta in ing  22 
microchannels were prepared by contact photo-
lithography using silicon patterns as molds. The 
microchannels had a width of 150 μm and a height of 
30 μm with a gap of 150 μm between the channels.
2.3 Synthesis of water-dispersed CdTe/CdS core-
shell aqQDs
Nearly monodispersed CdTe/CdS core-shell aqQDs 
were obtained via microwave irradiation as described 
in our previous work [24]. Briefl y, a CdTe precursor 
solution was prepared by adding freshly prepared 
NaHTe solution to N2-saturated CdCl2 solution at 
pH 8.4 in the presence of 3-mercaptopropionic acid 
(MPA) as the stabilizer. The precursor concentrations 
were [Cd] = 1.25 mmol/L, [MPA] = 3.0 mmol/L, and 
[Te] = 0.625 mmol/L. The CdTe precursor solution (50 
mL) was injected into glass bottle. CdTe nanocrystals 
(NCs) with a maximum emission wavelength of 
around 520 nm were prepared under microwave 
irradiation for 1 min at 100 °C. The CdTe NCs 
sample was removed when the temperature cooled 
to lower than 50 °C at room temperature. The as-
Figure 4 The dose-response calibration curve for CEA based on 
the aqQDs probe (λem=579 nm) and microfluidic network chip. 
The standard curve was fitted by a logistic model (Equation: 
y = 2 2 5 . 1 8 ± 2 9 . 2 1 + ( - 3 . 4 3 ± 1 2 . 4 5 - 2 2 5 . 1 8 ± 2 9 . 2 1 ) / ( 1 + 
(x / 2529665.20±2043790.60)0.26±0.06), R2=0.99). Background-
subtracted fluorescence intensity was used as the index. Insert 
(upper left): fl uorescent image of parallel detection of CEA samples 
(Concentrations: 0, 500 fmol / L, 5 pmol / L, 50 pmol / L, 500 pmol / L, 5 
nmol/L, 50 nmol / L, 500 nmol/L) in four parallel microfl uidic channels. 
Arrowheads indicate the fl ow directions
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prepared CdTe solution was reduced to one quarter 
of its original volume, and CdTe then precipitated 
with 2-propanol and separated by centrifugation. 
The colloidal precipitate was redissolved in 3 mL of 
ultrapure water, to give CdTe core NCs. The CdTe/
CdS precursor solution was prepared by adding 
the as-prepared CdTe core NCs to a N2-saturated 
solution with the concentrations of 1.25 mmol/L 
CdCl2, 1.0 mmol/L Na2S, and 6.0 mmol/L MPA at 
pH 8.4. The CdTe/CdS precursor solution (4 mL) was 
injected into the exclusive vitreous vessel. A series 
of high quality CdTe/CdS NCs with different sizes 
were obtained by regulating the time of microwave 
irradiation. After microwave irradiation, the CdTe/
CdS NCs sample was removed when the temperature 
cooled to lower than 50 °C at room temperature. 
No post-preparative treatment was performed on 
any of the samples prior to optical characterization. 
Samples were precipitated by 2-propanol and dried 
in a vacuum oven for XRD and XPS characterization. 
TEM, HRTEM, and EDAX samples were prepared 
by dropping the aqueous CdTe/CdS solution onto 
carbon-coated copper grids with the excess solvent 
being evaporated. The PL QY at room temperature 
was estimated using rhodamine 6G (R6G) (QY=95%), 
rhodamine 640 (R640) (QY=100%), or Oxazine 4 
(LD690) (QY=63%) in ethanol, according to the 
different maximum emission wavelengths of the 
CdTe/CdS core-shell NCs.
2.4 Preparation and validation of avidin linked 
aqQDs probes
The conjugation of MPA-capped aqQDs with avidin 
was performed as previously reported [10, 35, 36]. 
Avidin, a positively charged protein, is able to 
interact with the negatively charged MPA-capped 
QDs. An optimal protocol is as follows. QDs (1.2 
nmol) and avidin (1.2 nmol) were mixed and the fi nal 
volume of mixture was brought to 600 μL using PBS 
buffer (pH 7.4, 150 mmol/L Na2HPO4·12H2O, 150 
mmol/L KH2PO4, 136 mmol/L NaCl, and 2 mmol/
L KCl). The mixture was incubated in the dark at 
room temperature for 30 min and then ultrafiltered 
using 30K Nanosep centrifugal devices at 5000 
rpm for 20 min. The filtrate containing free non-
conjugated QDs was then removed. The upper phase 
containing QDs-avidin conjugates was concentrated 
to about 10 μmol/L. These conjugates showed a 
bright photoluminescence and were stored at 4 °C 
in the dark for subsequent use. For the preparation 
of multicolored avidin linked QDs probes, two 
kinds of QDs with different sizes were used: one 
with the maximum emission wavelength of 554 nm 
(orange under UV irradiation) and the other with the 
maximum emission wavelength of 579 nm (red under 
UV irradiation).
Mouse immunoglobulin was dissolved in PBS 
(150 mmol/L, pH 7.0, 40% glycerol) at a series 
of concentrations (32 pmol/L – 3.2 μmol/L). The 
solutions were immobilized on the chip through 
microchannels of the fi rst PDMS layer and incubated 
at 37 °C for 1 h. The chip was then washed with 
PBS containing 0.25% Tween 20 and blocked with 
PBS containing 5% BSA. Then biotinylated anti-
mouse polyclonal antibody with concentration 0.37 
mg/mL (10 μL of 3.7 mg/mL antibody mixed with 
25 μL 20% BSA and 65 μL PBS of 150 mmol/L at pH 
7.0) was passed into the slide through the second 
PDMS layer. The antibody recognized and bound 
to the mouse immunoglobulin at cross sections of 
the microchannels in the first and second PDMS 
layers. After incubation at 37 °C for 1 h, the chip was 
carefully rinsed to remove unbound biotinylated 
secondary antibody. QDs-conjugated avidin (or FITC-
conjugated avidin) was used as a signaling probe. 
After incubation for 15 min, fluorescent signals 
were fixed with GSH and the resulting array was 
imaged using fl uorescence microscopy. An additional 
photobleaching test was performed to compare the 
photostability of the QDs probe with that of organic 
dyes.
2.5 Detection of tumor markers using protein chips
The first monoclonal antibodies (C1300-02, 0.5 
mg/mL, dissolved in PBS of concentration 150 
mmol/L, pH 7.4, 40% glycerol) were deposited on 
the aldehyde-activated chip base through the first 
PDMS layer. After incubation at 37 °C for 1 h, the 
microchannels were rinsed and then the fi rst PDMS 
layer was peeled off. The slide was rinsed at least 
three times with the washing buffer (150 mmol/L 
PBS, 0.25% Tween 20) and blocked with the blocking 
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buffer (150 mmol/L PBS, pH 7.4, 5% BSA) for 30 
min. A second PDMS layer was then attached to the 
surface of the slide, with microchannels crossing the 
first pattern (Fig. S-1 in the ESM). Then a range of 
concentrations (500 fmol/L – 500 nmol/L, dissolved 
in PBS (150 mmol/L, pH 7.4, 2% BSA)) of CEA 
solutions was passed through the second PDMS layer. 
After incubation at 37 °C for 1 h and repeated rising 
steps, biotinylated monoclonal antibody (C1300-07A, 
0.2 mg/mL) was introduced to the cross areas where 
they bound to the target protein. After a rinsing step 
that removed unbound antibodies, avidin-coated 
aqQDs were used to probe the binding process. After 
15 min, fl uorescence signals were further fi xed by a 
solution of reduced L-glutathione (GSH). Finally, the 
second PDMS layer was removed and the chips were 
imaged with a fluorescence microscope (AxioSkop, 
ZEISS) equipped with optical filters and a charge-
coupled camera (AxioCam MRC5, ZEISS). Signals 
were excited at 365 nm ± 12 nm and 450 490 nm 
(power: 100 W; gain: 1; exposure time: 1028 ms). 
Fluorescence intensity was calculated from the image 
using software written in-house.
3. Conclusions
In summary, we have successfully demonstrated a 
novel NMIPC system for protein detection, which has 
several advantages. Firstly, the use of aqQDs as the 
signaling probe offers high quantum yield and high 
photostability, which leads to highly sensitive and 
robust protein chips. Secondly, the broad excitation 
band of aqQDs offers the potential for multiplex 
detection within a single chip. Thirdly, the use of a 
μFN avoids expensive automated spotting robots and 
provides an ideal environment for protein binding 
assays, including the ease of sample delivery and 
protein binding. We thus expect this NMIPC system 
will be a promising tool for molecular diagnostics 
and proteomics.
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